Gordagen Pharmaceuticals

Gordagen Pharmaceuticals is an Australian private company that develops new therapies for hyperlipidemia, diabetes, inflammatory diseases, and cardiovascular diseases using tocotrienols (T3). The company conducts research, development, and production of natural tocotrienol-based drugs in the fields of exercise and heart health.